当前位置:首页 - 行情中心 - 康泰生物(300601) - 财务分析

康泰生物

(300601)

  

流通市值:123.93亿  总市值:156.26亿
流通股本:8.86亿   总股本:11.17亿

康泰生物(300601)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年第一季度实现净利润0.22亿元,每股收益0.02元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年第一季度最新股东权益968339.42万元,未分配利润219782.18万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年第一季度最新总资产1425492.76万元,负债457153.35万元。

利润表
报告期2025-03-312024-12-312024-09-302024-06-30
营业总收入645,202,778.572,651,715,620.992,018,201,664.481,202,065,325.16
营业总成本594,453,971.642,301,437,136.571,597,573,808.721,012,244,950.53
营业利润28,137,574.33181,224,375.2341,131,333.85142,693,649.72
利润总额26,969,177.44149,936,979.79334,461,343.35136,690,436.85
净利润22,385,110.07201,553,722.8351,075,774.02165,352,012.64
其他综合收益-56,881.31-90,939.67-137,744.56-54,412.97
综合收益总额22,328,228.76201,462,783.13350,938,029.46165,297,599.67
资产负债表
报告期2025-03-312024-12-312024-09-302024-06-30
流动资产合计6,229,532,545.456,242,288,938.395,850,624,265.744,519,343,242.76
非流动资产合计8,025,395,103.098,321,425,556.948,664,915,448.759,926,112,613.44
资产总计14,254,927,648.5414,563,714,495.3314,515,539,714.4914,445,455,856.2
流动负债合计2,327,486,213.632,647,146,164.792,618,772,615.832,692,290,914.07
非流动负债合计2,244,047,248.682,255,542,981.532,187,278,889.282,218,476,318.5
负债合计4,571,533,462.314,902,689,146.324,806,051,505.114,910,767,232.57
归属于母公司股东权益合计9,683,541,738.339,661,123,922.629,709,508,043.449,534,672,956.28
股东权益合计9,683,394,186.239,661,025,349.019,709,488,209.389,534,688,623.63
负债和股东权益合计14,254,927,648.5414,563,714,495.3314,515,539,714.4914,445,455,856.2
现金流量表
报告期2025-03-312024-12-312024-09-302024-06-30
经营活动现金流入小计581,746,831.932,933,618,620.582,027,717,804.921,274,368,208.63
经营活动现金流出小计628,050,249.912,330,368,915.751,791,512,554.061,216,846,924.96
经营活动产生的现金流量净额-46,303,417.98603,249,704.83236,205,250.8657,521,283.67
投资活动现金流入小计60,089,822.74862,894,399.8758,913,299.43758,571,260.26
投资活动现金流出小计125,315,698.651,419,581,999.181,316,775,185.541,053,829,705.89
投资活动产生的现金流量净额-65,225,875.91-556,687,599.38-557,861,886.11-295,258,445.63
筹资活动现金流入小计25,584,357.78224,226,982.25214,126,982.25200,135,232.71
筹资活动现金流出小计124,526,138.31,024,984,900.02890,531,896.66834,075,650.64
筹资活动产生的现金流量净额-98,941,780.52-800,757,917.77-676,404,914.41-633,940,417.93
汇率变动对现金及现金等价物的影响-62,987.62-60,732.33-186,029.74-38,810.62
现金及现金等价物净增加额-210,534,062.03-754,256,544.65-998,247,579.4-871,716,390.51
期末现金及现金等价物余额205,535,192.42416,069,254.45172,078,219.7298,609,408.59
最新报告期:2025-04-25
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
西南证券杜向阳0.340.430.522025-04-25
中信建投汤然,刘若飞,贺菊颖0.180.350.482025-04-25
中信建投汤然,刘若飞,贺菊颖0.180.350.482025-04-21
华泰证券代雯,张云逸0.410.490.602025-04-21
中国银河程培0.270.370.462025-04-21
TOP↑